Multiple Sclerosis Oral Treatment Approved in Canada
Links shared publicly online about this topic.
- 449total visits
Multiple Sclerosis Oral Treatment Approved in Canada
View full resource at disabled-world.com
Tags: Multiple Sclerosis, Disease and Condition, disease
Most Recently Shared on March 10, 2011 at 2:50 pm By:
Multiple Sclerosis Oral Treatment Approved in Canada http://ff.im/-zovzM
PharmaLive: Novartis Receives European Commission Approval for Gilenya, the First Oral Multiple Sclerosis Treatment for Use in the EU
pharmalive.com — “PharmaLive: Novartis Receives European Commission Approval for Gilenya, the First Oral Multiple Sclerosis Treatment for Use in the EU” View full resource at pharmalive.com
Most Recently Shared on March 22, 2011 at 12:15 pm By:
PharmaLive Pharma and Health News
Daily Advantage - EU OKs Gilenya; Jevtana - http://tinyurl.com/4v5lktu
Novartis Receives European Commission Approval For Gilenya(R), The First Oral Multiple Sclerosis Treatment For Use In The EU
medicalnewstoday.com — “The European Commission has granted Novartis approval for Gilenya® (fingolimod) 0.5 mg daily as a disease modifying therapy in patients with highly active relapsing-remitting multiple sclerosi” View full resource at medicalnewstoday.com
Most Recently Shared on March 22, 2011 at 12:06 pm By:
Novartis Receives European Commission Approval For Gilenya(R), The First Oral Multiple Sclerosis Treatment For U... http://bit.ly/frRVEL
Novartis Receives European Commission Approval For Gilenya(R), The First Oral Multiple Sclerosis Treatment For Use In The EU
medicalnewstoday.com — “The European Commission has granted Novartis approval for Gilenya® (fingolimod) 0.5 mg daily as a disease modifying therapy in patients with highly active relapsing-remitting multiple sclerosi” View full resource at medicalnewstoday.com
Most Recently Shared on March 22, 2011 at 7:05 am By:
Novartis Receives European Commission Approval For Gilenya(R), The First Oral Multiple Sclerosis Treatment For Use In ... http://mnt.to/3SwC
Novartis receives European Commission approval for Gilenya®, the first oral multiple sclerosis treatment for use in the EU | wallstreet:online
wallstreet-online.de — “Novartis International AG / Novartis receives European Commission approval for Gilenya®, the first oral multiple sclerosis treatment for use in the EU Processed and transmitted by Thomson Reuters. The issuer is solely responsible for the content ...” View full resource at wallstreet-online.de
Most Recently Shared on March 21, 2011 at 11:52 am By:
Novartis receives European Commission approval for Gilenya®, the first oral multiple sclerosis treatment for use... http://bit.ly/hwQiDF
UPDATE 1-Novartis receives EU approval for Gilenya | Reuters
reuters.com — “* Gilenya is first oral multiple sclerosis treatment in EU * European green light follows U.S. approval in September * Gilenya seen as potential blockbuster (Adds further details, background)” View full resource at reuters.com
Most Recently Shared on March 21, 2011 at 10:28 am By:
John Carroll Health Communicator
Novartis gains EU approval for MS pill Gilenya in Europe. Another solid, unsurprising step forward. http://reut.rs/fKwS3V
First Oral Treatment For People With Multiple Sclerosis Approved In Canada
medicalnewstoday.com — “Novartis Pharmaceuticals Canada Inc. announced that its new MS treatment, Gilenya™ (fingolimod), has received Notice of Compliance in Canada. Gilenya™ (fingolimod) is the first disease” View full resource at medicalnewstoday.com
Most Recently Shared on March 12, 2011 at 12:33 am By:
First Oral Treatment For People With Multiple Sclerosis Approved In Canada: Novartis Pharmaceuticals Canada Inc.... http://bit.ly/eBgeHS
Multiple sclerosis pill approved for use in Canada - Brantford Expositor - Ontario, CA
brantfordexpositor.ca — “Canada has one of the highest multiple sclerosis rates in the world, but sufferers in this country will soon have a new treatment option. People...” View full resource at brantfordexpositor.ca
Most Recently Shared on March 11, 2011 at 4:04 pm By:
Multiple sclerosis pill approved for use in Canada: Canada has one of the highest multiple sclerosis rates in th... http://bit.ly/hYjWAn
First Oral Treatment For People With Multiple Sclerosis Approved In Canada
medicalnewstoday.com — “Novartis Pharmaceuticals Canada Inc. announced that its new MS treatment, Gilenya™ (fingolimod), has received Notice of Compliance in Canada. Gilenya™ (fingolimod) is the first disease” View full resource at medicalnewstoday.com
Most Recently Shared on March 11, 2011 at 4:04 pm By:
First Oral Treatment For People With Multiple Sclerosis Approved In Canada: Novartis Pharmaceuticals Canada Inc.... http://bit.ly/fK3bsx
1st MS pill approved in Canada - Health - CBC News
cbc.ca — “An oral drug for multiple sclerosis is approved for some MS patients in Canada.” View full resource at cbc.ca
Most Recently Shared on March 11, 2011 at 3:03 pm By:
Nat Bourre Health Social Media
Could be a welcome alternative for patients: RT @ExtensoIntel 1st MS pill approved in Canada Gilenya from #Novartis http://goo.gl/XXzgj
First Oral Treatment For People With Multiple Sclerosis Approved In Canada
medicalnewstoday.com — “Novartis Pharmaceuticals Canada Inc. announced that its new MS treatment, Gilenya™ (fingolimod), has received Notice of Compliance in Canada. Gilenya™ (fingolimod) is the first disease” View full resource at medicalnewstoday.com
Most Recently Shared on March 11, 2011 at 10:05 am By:
First Oral Treatment For People With Multiple Sclerosis Approved In Canada http://mnt.to/3S92 #multiplesclerosis
Novartis Gains Positive CHMP Opinion For Gilenya(R), First Oral Multiple Sclerosis Treatment Recommended For Approval In The European Union
medicalnewstoday.com — “The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Gilenya® (fingolimod) 0.5 mg daily as a disease modifying therapy in patie” View full resource at medicalnewstoday.com
Most Recently Shared on January 24, 2011 at 12:24 pm By:
Novartis Gains Positive CHMP Opinion For Gilenya(R), First Oral Multiple Sclerosis Treatment Recommended For App... http://mnt.to/f/3Qm2
Novartis gains positive CHMP opinion for Gilenya®, first oral multiple sclerosis treatment recommended for approval in the European Union
novartis.com — “Novartis gains positive CHMP opinion for Gilenya®, first oral multiple sclerosis treatment recommended for approval in the European Union” View full resource at novartis.com
Most Recently Shared on January 21, 2011 at 1:31 pm By:
eyeonfda Pharma and Health Lawyer
Novartis gets positive CHMP opinion for Gilenya®, 1st oral multiple sclerosis treatment approved in EU http://ow.ly/3HNFl
Merck Serono to Appeal Negative CHMP Opinion on Cladribine in MS - QualityPoint Technologies
qualitypointtech.net — “The company has notified the European Medicines Agency it intends to appeal the decision that derailed hopes for European approval of the oral treatment for multiple sclerosis. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on October 13, 2010 at 9:36 pm By:
Merck Serono to Appeal Negative CHMP Opinion on Cladribine in MS: The company has notified the European Medicines ... http://bit.ly/bvxVFb
Biogen Idec Makes Statement About U.S. FDA Approval Of Gilenya" - QualityPoint Technologies
qualitypointtech.net — “Biogen Idec is committed to improving the lives of people with multiple sclerosis (MS), and no company is doing more for these patients. There has been a desire within the MS community for an oral treatment for a long time, and the approval of Gilenya has made this a reality. MS impacts each person differently and, until we have a cure, there should be multiple treatments available to address the individual needs of patients...” View full resource at qualitypointtech.net
Most Recently Shared on September 26, 2010 at 4:36 pm By:
Biogen Idec Makes Statement About U.S. FDA Approval Of Gilenyaâ„¢: Biogen Idec is committed to improving the lives... http://bit.ly/acZdgQ
Advertisement
